WO2014044342A8 - Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen - Google Patents

Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen Download PDF

Info

Publication number
WO2014044342A8
WO2014044342A8 PCT/EP2013/002490 EP2013002490W WO2014044342A8 WO 2014044342 A8 WO2014044342 A8 WO 2014044342A8 EP 2013002490 W EP2013002490 W EP 2013002490W WO 2014044342 A8 WO2014044342 A8 WO 2014044342A8
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
carrier material
magnesium hydroxide
containing preparations
hydroxide carbonate
Prior art date
Application number
PCT/EP2013/002490
Other languages
English (en)
French (fr)
Other versions
WO2014044342A1 (de
Inventor
Guenter Moddelmog
Roberto Ognibene
Thorsten Wedel
Dieter Lubda
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to CN201380048184.2A priority Critical patent/CN104640569A/zh
Priority to EP13755955.5A priority patent/EP2897645A1/de
Priority to KR1020157010004A priority patent/KR20150058427A/ko
Priority to BR112015005621A priority patent/BR112015005621A2/pt
Priority to CA2885105A priority patent/CA2885105A1/en
Priority to US14/428,396 priority patent/US20150273062A1/en
Priority to JP2015532314A priority patent/JP6244363B2/ja
Publication of WO2014044342A1 publication Critical patent/WO2014044342A1/de
Publication of WO2014044342A8 publication Critical patent/WO2014044342A8/de
Priority to IL237741A priority patent/IL237741A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

Die vorliegende Erfindung betrifft feste Formulierungen, welche mindestens einen porösen Träger und eine oder mehrere funktionelle Substanzen in einer stabilen Mischung enthalten, sowie deren Verwendung.
PCT/EP2013/002490 2012-09-18 2013-08-19 Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen WO2014044342A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN201380048184.2A CN104640569A (zh) 2012-09-18 2013-08-19 在含活性成分的制剂中用作载体材料的碱式碳酸镁
EP13755955.5A EP2897645A1 (de) 2012-09-18 2013-08-19 Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen
KR1020157010004A KR20150058427A (ko) 2012-09-18 2013-08-19 활성 성분-함유 제제 중 담체 물질로서 탄산 수산화 마그네슘
BR112015005621A BR112015005621A2 (pt) 2012-09-18 2013-08-19 carbonato de hidróxido de magnésio como material veículo em preparações contendo ingredientes ativos
CA2885105A CA2885105A1 (en) 2012-09-18 2013-08-19 Magnesium hydroxide carbonate as carrier material in active ingredient-containing preparations
US14/428,396 US20150273062A1 (en) 2012-09-18 2013-08-19 Magnesium hydroxide carbonate as carrier material in active ingredient-containing preparations
JP2015532314A JP6244363B2 (ja) 2012-09-18 2013-08-19 有効成分を含有する製剤における担体材料としての水酸化炭酸マグネシウム
IL237741A IL237741A0 (en) 2012-09-18 2015-03-15 Magnesium hydroxide carbonate as a carrier in the preparation of preparations that include an active substance

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12006551 2012-09-18
EP12006551.1 2012-09-18
EP13000730 2013-02-13
EP13000730.5 2013-02-13

Publications (2)

Publication Number Publication Date
WO2014044342A1 WO2014044342A1 (de) 2014-03-27
WO2014044342A8 true WO2014044342A8 (de) 2015-02-12

Family

ID=49084960

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/002490 WO2014044342A1 (de) 2012-09-18 2013-08-19 Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen

Country Status (9)

Country Link
US (1) US20150273062A1 (de)
EP (1) EP2897645A1 (de)
JP (1) JP6244363B2 (de)
KR (1) KR20150058427A (de)
CN (1) CN104640569A (de)
BR (1) BR112015005621A2 (de)
CA (1) CA2885105A1 (de)
IL (1) IL237741A0 (de)
WO (1) WO2014044342A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11089804B2 (en) 2014-12-11 2021-08-17 Shin-Etsu Chemical Co., Ltd. Oil-in-water type composition and food using same
US10723807B2 (en) 2017-03-31 2020-07-28 Shin-Etsu Chemical Co., Ltd. Method for producing hydroxyalkyl alkyl cellulose
JP6423481B1 (ja) * 2017-04-28 2018-11-14 神島化学工業株式会社 炭酸マグネシウム
US20220160594A1 (en) * 2019-02-25 2022-05-26 Disruptive Materials Operations Ab Particulate amorphous mesoporous magnesium carbonate material
JP7093812B2 (ja) * 2019-06-27 2022-06-30 Ｄｏｗａエレクトロニクス株式会社 銀粉およびその製造方法
KR102483759B1 (ko) * 2022-01-18 2022-12-30 박민규 필러 조성물의 제조 방법
CN116515343A (zh) * 2023-05-24 2023-08-01 江西广源新材料有限公司 一种视黄酸/水菱镁复合粉体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242353A1 (de) * 1982-11-16 1984-05-30 Hoechst Ag, 6230 Frankfurt Lagerstabile, die wirkstoffe pyrazophos und captafol enthaltende mittel
JPH0768121B2 (ja) * 1987-07-21 1995-07-26 信越化学工業株式会社 固形薬剤のコ−ティング方法
DE3819926A1 (de) * 1988-06-11 1989-12-14 Gruenau Gmbh Chem Fab Verfahren zur verbesserung des fliessverhaltens von zum verklumpen neigenden pulvermischungen
JPH07114946B2 (ja) * 1988-10-24 1995-12-13 株式会社奈良機械製作所 難溶性物質の処理方法
JPH04228420A (ja) * 1990-06-04 1992-08-18 Tokuyama Soda Co Ltd 塩基性炭酸マグネシウム及びその製造方法
JPH04369375A (ja) * 1991-06-17 1992-12-22 Matsushita Refrig Co Ltd 冷蔵庫
JPH05194275A (ja) * 1991-09-03 1993-08-03 Takeda Chem Ind Ltd 製剤用組成物、固形製剤および薬物の防臭方法
JP3005883B2 (ja) 1992-12-28 2000-02-07 富士化学工業株式会社 リン酸水素カルシウムの製造方法およびそれを用いた賦形薬
JP2700141B2 (ja) 1993-09-17 1998-01-19 富士化学工業株式会社 リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
US20020072602A1 (en) * 2000-07-07 2002-06-13 Claude Singer Micronized mirtazapine
JP3910495B2 (ja) * 2002-02-13 2007-04-25 日鉄鉱業株式会社 塩基性炭酸マグネシウム及びその製造方法、並びに該塩基性炭酸マグネシウムを含有する組成物又は構造体
JP3910555B2 (ja) * 2002-09-17 2007-04-25 日鉄鉱業株式会社 中空担体及び機能性粒子、並びにそれらの製造方法
JP4274963B2 (ja) * 2004-02-04 2009-06-10 株式会社日本色材工業研究所 固形粉末化粧料
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
EP2531178B1 (de) * 2010-02-03 2014-06-04 Merck Patent GmbH Direkt verpressbares magnesiumhydroxidcarbonat
WO2011095669A1 (en) 2010-02-04 2011-08-11 Nokia Corporation Adjusting channel access parameters due to traffic load
FR2967913A1 (fr) * 2010-11-29 2012-06-01 Vetalis Composition galenique adaptee a l'administration a un animal non-humain, utilisations de celle-ci et methodes associees

Also Published As

Publication number Publication date
IL237741A0 (en) 2015-05-31
CN104640569A (zh) 2015-05-20
WO2014044342A1 (de) 2014-03-27
BR112015005621A2 (pt) 2017-07-04
CA2885105A1 (en) 2014-03-27
JP2015530393A (ja) 2015-10-15
KR20150058427A (ko) 2015-05-28
JP6244363B2 (ja) 2017-12-06
EP2897645A1 (de) 2015-07-29
US20150273062A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
WO2014044342A8 (de) Magnesiumhydroxidcarbonat als trägermaterial in wirkstoffhaltigen zubereitungen
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
EP3736282C0 (de) Zellpenertrierendes peptid, konjugat damit und zusammensetzung mit dem konjugat
EP2899199A4 (de) Zellpenetrierendes peptid, konjugat damit und zusammensetzung mit dem konjugat
WO2012149173A3 (en) Methods and compositions using calcium carbonate and stabilizer
IL225926A0 (en) Boronate compounds, preparations containing them and their uses
EP2899201A4 (de) Zellpenetrierendes peptid, konjugat damit und zusammensetzung mit dem konjugat
WO2011138678A3 (en) Compositions, gels and foams with rheology modulators and uses thereof
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
WO2010021607A3 (en) Pharmaceutical formulation
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
WO2012002730A3 (ko) 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물
WO2011122872A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물 포함 조성물
EP2848122A4 (de) Neue pestizideinschlusskomplexe, zusammensetzungen mit besagten komplexen und verwendung davon als schädlingsbekämpfungsmittel
EP2687549A4 (de) Hochverzweigtes lipophiles polymer und photopolymerisierbare zusammensetzung damit
EP2784061A4 (de) Acylhydrazon- und oxadiazolverbindungen, diese enthaltende pharmazeutische zusammensetzungen und verwendungen davon
EP2871187A4 (de) Neuartige verbindung oder pharmazeutisch unbedenkliches salz davon und pharmazeutische zusammensetzung damit als wirkstoff
WO2012061360A3 (en) Pharmaceutical compositions
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
MX2014009871A (es) Formulacion farmaceutica que tiene estabilidad mejorada.
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
EP2910246A4 (de) Pharmazeutische zusammensetzung zur prävention oder behandlung von krebs mit enoblock als wirkstoff
WO2013064388A3 (de) Kosmetische formulierung enthaltend n-acyl - phytosphingosin
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13755955

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 237741

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2885105

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14428396

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2015532314

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112015005621

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20157010004

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112015005621

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150313